Rchr
J-GLOBAL ID:200901095588523194   Update date: Apr. 12, 2024

Habuchi Tomonori

ハブチ トモノリ | Habuchi Tomonori
Affiliation and department:
Homepage URL  (1): http://www.med.akita-u.ac.jp/~hinyoki/default.html
Research field  (1): Urology
Research keywords  (2): 泌尿器腹腔鏡手術 ,  泌尿器科腫瘍学
Research theme for competitive and other funds  (39):
  • 1991 - 2030 泌尿器科腫瘍学
  • 1991 - 2030 Urologic Oncology
  • 2021 - 2025 Molecular mechanisms and target molecules associated with progression and treatment resistance of urologic cancers associated with microbiome alterations by diet and obesity
  • 2016 - 2021 Molecular analysis and delineation of the mechanisms underlying progression of urogenital cancers and alteration of tumor immuno-microenvironment associated with adiposity enhancement
  • 2015 - 2020 Practical application of glycan-targeted biomarker to prevent over-diagnosis and over-treatment of prostate cancer
Show all
Papers (545):
  • Mizuki Kobayashi, Kazuyuki Numakura, Shingo Hatakeyama, Toshiya Ishida, Atsushi Koizumi, Kazuki Tadachi, Ryoma Igarashi, Koichiro Takayama, Yumina Muto, Yuya Sekine, et al. Real clinical outcomes of nivolumab plus ipilimumab for renal cell carcinoma in patients over 75 years old. International journal of clinical oncology. 2023. 28. 11. 1530-1537
  • Kazuyuki Numakura, Mizuki Kobayashi, Yumina Muto, Hiromi Sato, Yuya Sekine, Ryuta Sobu, Yu Aoyama, Yoshiko Takahashi, Syuhei Okada, Hajime Sasagawa, et al. The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer. Current oncology (Toronto, Ont.). 2023. 30. 9. 8092-8110
  • Kazuyuki Numakura, Yuya Sekine, Shingo Hatakeyama, Yumina Muto, Ryuta Sobu, Mizuki Kobayashi, Hajime Sasagawa, Soki Kashima, Ryohei Yamamto, Taketoshi Nara, et al. Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma. Cancer medicine. 2023. 12. 16. 16837-16845
  • Takafumi Yanagisawa, Kenichi Hata, Shintaro Narita, Shingo Hatakeyama, Keiichiro Mori, Yuji Yata, Takayuki Sano, Takashi Otsuka, Shuhei Hara, Keiichiro Miyajima, et al. Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer with focus on efficacy of sequential therapy. The Prostate. 2023. 83. 6. 563-571
  • Renpei Kato, Sei Naito, Kazuyuki Numakura, Shingo Hatakeyama, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Shuya Kandori, Sadafumi Kawamura, Yoichi Arai, et al. Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study. International journal of clinical oncology. 2023. 28. 5. 726-727
more...
MISC (824):
  • 藤山 信弘, 齋藤 満, 山本 竜平, 提箸 隆一郎, 齋藤 拓郎, 青山 有, 沼倉 一幸, 羽渕 友則. 長期フォロー腎移植患者CNI血中濃度が与えるde novo DSA発生への影響. 日本腎臓病薬物療法学会誌. 2022. 11. 特別号. S162-S162
  • 成田 伸太郎, 齋藤 満, 羽渕 友則. 【新規保険収載ロボット支援手術手技を極める】ロボット支援腎尿管全摘除術. 泌尿器外科. 2022. 35. 9. 954-959
  • 天野 賢士, 嘉島 相輝, 小泉 淳, 南條 博, 赤井 太郎, 明円 真吾, 安達 尚宣, 川村 貞文, 山本 竜平, 奈良 健平, et al. Carney複合に合併した難治性性索間質性腫瘍の1例. 泌尿器外科. 2022. 35. 9. 1021-1021
  • 佐々木 禎, 奈良 健平, 小泉 淳, 石田 雅則, 青山 有, 梶原 知佳, 嘉島 相輝, 山本 竜平, 沼倉 一幸, 齋藤 満, et al. 診断に難渋したIVC浸潤を伴う腫瘍マーカー陰性NSGCTの1例. 泌尿器外科. 2022. 35. 9. 1022-1022
  • 佐藤 博美, 成田 伸太郎, 石田 雅宣, 高橋 佳子, 黄 明国, 嘉島 相輝, 山本 竜平, 小泉 淳, 奈良 健平, 沼倉 一幸, et al. ラード食による前立腺癌発症・増殖における腸内細菌環境の解析(Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression). 日本癌学会総会記事. 2022. 81回. J-3038
more...
Books (3):
  • 泌尿器がんのすべて : 患者さんへの説明にそのまま使える!
    メディカ出版 2013 ISBN:9784840443180
  • ベッドサイド泌尿器科学
    南江堂 2013 ISBN:9784524250370
  • 老化に伴う泌尿器癌発症におけるメチル化異常の病態解析
    [羽渕友則] 2002
Education (2):
  • 1991 - Kyoto University Graduate School of Medicine
  • 1980 - 1986 Kyoto University Faculty of Medicine
Professional career (1):
  • 医学博士 (京都大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page